Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 3308
Selected: 0
NCT IDTitle
NCT00002463Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors
NCT00501319Measurement of Pain and Other Symptoms of Non-Small Cell Lung Cancer (NSCLC) Patients Following Thoracic Surgery
NCT01938716Gemcitabine Pharmacokinetics After Preoperative Chemoradiation Therapy
NCT02250937Venetoclax and Sequential Busulfan, Cladribine, and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
NCT00496119Proton Beam Therapy for Chordoma Patients
NCT00390793Combination Chemotherapy and Dasatinib in Treating Participants With Philadelphia Positive or BCR-ABL Positive Acute Lymphoblastic Leukemia.
NCT05042934Lurbinectedin With or Without Irinotecan in Treating Patients With Relapsed or High Risk Metastatic Ewing Sarcoma
NCT01334021Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast Cancer
NCT00003645Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence
NCT03330028Study of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology
NCT00905034Methotrexate, Vincristine, Pegylated L-Asparaginase and Dexamethasone (MOAD) in Acute Lymphoblastic Leukemia (ALL) Salvage
NCT05196867Liver Cancer Prevention Randomized Control Trial
NCT00766636Preoperative Chemotherapy (Gemcitabine and Erlotinib) With or Without Radiation Therapy
NCT06284564A Phase II Study Bolstering Outcomes by Optimizing Immunotherapy Strategies With Evolocumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma (BOOST-RCC)
NCT02389309Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients With Advanced, Recurrent, or Refractory Solid Tumors
NCT01332630TPI 287 in Breast Cancer Metastatic to the Brain
NCT02629809Ibrutinib, Fludarabine Phosphate, Cyclophosphamide, and Obinutuzumab in Treating Patients With Chronic Lymphocytic Leukemia
NCT05904899An Evaluation of the Implementation of the Care and Monitoring at Home Program- A New Paradigm for Acute Care Management of Cancer Patients
NCT03177460Daratumumab or FMS Inhibitor JNJ-40346527 Before Surgery in Treating Patients With High-Risk, Resectable Localized or Locally Advanced Prostate Cancer
NCT04879121Larotrectinib for the Treatment of NTRK Amplification Positive, Locally Advanced or Metastatic Solid Tumors
NCT00664404Genetic Differences in Limbic Activation Associated With Nicotine Withdrawal
NCT00350818Azacitidine Maintenance Therapy After Allogeneic Bone Marrow Transplantation (Allo BMT)
NCT00794820Fludarabine, Cyclophosphamide, and Rituximab - High Dose Frontline
NCT06507878Global Real World Data in Patients With Advanced Thyroid Cancer on Standard of Care and Specialized Interventions- Registry of Oncologic Outcomes With Testing and Treatment.
NCT07241715Conversion Surgery for Gastric Cancer With Peritoneal Metastases (CONVERGENCE)
NCT03471260Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
NCT04771520Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors
NCT03696784Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma
NCT01542684Study of Azacytidine Followed by GM-CSF in Patients With Myelodysplastic Syndrome (MDS)
NCT07127926Evaluation of Belumosudil Whole Tablets vs. Crushed Tablets Pharmacokinetics in Patients Suffering From Chronic GvHD
NCT05059717An Investigational Scan (MR DENSE) in Detecting Early Chemotherapy-Related Liver Injury Before Surgery in Patients With Resectable Colorectal Liver Metastases
NCT01189513SCH-900105 in Recurrent Glioblastoma
NCT00002682Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach
NCT05961696A Phase I Study of Mosunetuzumab for Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
NCT03953131Gallium Ga 68-DOTATATE PET/CT in Predicting Tumor Growth in Patients With Meningiomas
NCT020574453rd Party LMP1/2-Specific Cytotoxic T Lymphocytes for EBV-Associated Lymphoma
NCT05842031Assessment of Patient Experience and Needs for Patients Undergoing Invasive Inguinal Lymph Node Procedures for Penile Cancer
NCT07335302CARE-BI:a Pilot Study to Improve Patient Comfort and Reduce Psychological Distress During IA Removal
NCT00385788Allogeneic Blood Stem Cell Transplantation and Adoptive Immunotherapy for Hodgkin's Disease
NCT01266070TKI 258 in Von Hippel-Lindau Syndrome (VHL)
NCT05243641Neratinib and Capmatinib Combination (Phase Ib/II) in Metastatic Breast Cancer and Inflammatory Breast Cancer Patients With Abnormal HER-family and c-Met Pathway Activity as Measured by the CELsignia Signaling Analysis Test
NCT00502905Busulfan and Fludarabine in Patients With AML and MDS
NCT03207529Alpelisib and Enzalutamide in Treating Patients With Androgen Receptor and PTEN Positive Metastatic Breast Cancer
NCT04062305nTMS in Planning Stereotactic Radiosurgery in Patients With Brain Metastases in the Motor Cortex
NCT07728370RISE: Reducing Cancer and HIV Stigma Through Empowerment
NCT02018653CASAD for Severe Diarrhea in the Emergency Department
NCT05836870Tele-PancFit: A Multi-site Trial of Video-based Strengthening Exercise Prehabilitation for Patients With Resectable Pancreatic Cancer
NCT01624766Everolimus and Anakinra or Denosumab in Treating Participants With Relapsed or Refractory Advanced Cancers
NCT07283731Phase 2 Trial of Zanzalintinib and Pembrolizumab in Select Subtypes of Advanced/Metastatic Soft-tissue Sarcoma
NCT00968253RAD001 Study in Treatment of Relapsed or Refractory Acute Lymphocytic Leukemia